| Literature DB >> 32400121 |
Emitis Natali Naeini1, Mandana Atashkadeh2, Hugo De Bruyn3,4, Jan D'Haese5.
Abstract
BACKGROUND: The advent of computer-guided surgery removed the need for complex surgical interventions such as extensive flap elevations, second stage implant exposure, and complications usually associated with conventional protocols.Entities:
Keywords: accuracy; complications; computer-assisted; dental implants; research ethics
Mesh:
Substances:
Year: 2020 PMID: 32400121 PMCID: PMC7496427 DOI: 10.1111/cid.12901
Source DB: PubMed Journal: Clin Implant Dent Relat Res ISSN: 1523-0899 Impact factor: 3.932
FIGURE 1(A), Projection of the planned (green) and postoperative (red) implant position on the mesio‐distal plane (yellow) (left) and the planar view (right). (B), In plane implant calculations. Orthogonal projection of the postoperative (red) on the planned (green) position. a, shoulder point projection; b, tip point projection; c, angular deviation; d, depth deviation
FIGURE 2Search process and generated outcome of search 1 focusing on the general aspects
FIGURE 3Search process and generated outcome of search 2 focusing on accuracy
Overview of the selected papers, reporting implant outcome variables, complications, and scientific level of evidence as described by the Oxford Centre for Evidence‐Based Medicine (2011)
| Author | Design | Protocol | Number of studies included | Number of implants analyzed | Mean CSR (%) ± SD (%) | Range CSR (%) | Follow‐up in months Mean [Range] | Mean marginal bone level changes (mm) (SD) [range] | Mean prosthetic survival (%) | Scientific level of evidence |
|---|---|---|---|---|---|---|---|---|---|---|
| Moraschini et al 2015 | SR + M‐A | GS | 13 | 2019 |
97 +/− 3,49 | 89,2‐100 |
22,6 [12‐48] |
1,45 (NR) [0.83‐1.9] | 83.9‐100 | 1 |
| Voulgarakis et al 2014 | SR |
Overall F‐FL G‐FL |
23 4 17 | NR |
NR NR NR |
89‐100 98,3‐100 89‐100 |
NR [12‐120] NR [12–48] NR [12‐60] |
NR (NR) [NR] NR (NR) [0.09‐1.40] NR (NR), [0.55‐2.6] | NR | 1 |
| Lin et al 2014 | SR + M‐A |
Overall FL CS | 12 | NR |
NR 97,0 98,6 |
NR 90‐100 91,2–100 | 16.1 [6‐39] |
0.03 −0.11‐0.18 | NR | 1 |
| Vohra et al 2015 | SR |
Overall CS and F‐FL |
10 10 | 576 | NR | NR | NR [2.5‐48] | NR (NR) [1.35‐1.9] | NR | 1 |
Abbreviations: CS, conventional surgery; CSR, cumulative survival rate; F‐FL, freehanded flapless; FL, flapless; G‐FL, guided flapless; GS, guided surgery; M‐A, meta‐analysis; NR, not reported; SR, systematic review.
Overview of the review papers reporting on complications encountered during surgery and postoperatively
| Author | Design | Protocol | Number of studies reporting on complications/total number of studies included | Complications mentioned by the authors | ||
|---|---|---|---|---|---|---|
| Intraoperative events | Postoperative events | Postoperative prosthetic | ||||
| Moraschini et al 2015 | SR + M‐A | GS | 12/13 |
(Number of Occurrences in total) Low implant stability (10) Fracture of guide (7) Misfit of the guide (6) Implant fenestration (4) |
(% of all implants included in the study) Implant failure (3%) Infections (8%) Low primary stability (10%) Persistent pain (2%) Peri‐implantitis (14%) |
(% of all implants included in the study) Fracture of resin (13%) Loosening of component (7%) Extensive occlusal adjustments (3%) Misfits (9%) |
| Voulgarakis et al 2014 | SR |
Overall F‐FL G‐FL | 17/23 |
Complications reported in 9/23 studies; Fracture of guide (6‐10%) Fenestrations (3%) Bone dehiscences (2%) |
Reported in 12/23 studies: Pain (5/12) Implant mobility (7/12) Absence of keratinized mucosa (7/12) Peri‐implantitis(7/12) |
Reported in 14/23 studies: Fracture of the guide in (8/14) Adjustments due to misfit in (8/14) Loosening of components in (6/14) |
Abbreviations: CS, conventional surgery; F‐FL, freehanded flapless; FL, flapless; G‐FL, guided flapless; GS, guided surgery; M‐A, meta‐analysis; NR, not reported; SR, systematic review.
Overview of the review papers reporting on accuracy and complications with guided 3D‐surgery
| Author | Design | Number of studies | Mean coronal deviation (mm); [95% CI]; (n sites) | Mean apical deviation (mm); [95% CI]; (n sites) | Mean angular deviation (°); [95% CI]; (n sites) | Complications | Scientific Level of Evidence |
|---|---|---|---|---|---|---|---|
| Schneider et al (2009) | SR + M‐A | 8 accuracy studies + 10 clinical studies | 1.07 mm; [0.76‐1.22] (321) | 1.63 mm; [1.26‐2.0] (281) | 5.26 mm [3.94‐6.58] (321) |
2.5% on implant level
18.8% of the patients had prosthetic complications 7.3% of patients had misfit between abutment and prosthesis
| 1 |
| Tahmaseb et al (2014) | SR + M‐A | 24 accuracy studies/14 clinical studies | 1.12 mm; [0.0‐4.5]; (1530) | 1.39 mm; [0.3‐7.1] (1465) | 3.89 mm; [0‐21.16] (1854) |
125 patients of 434 patients treated (36.4%),
Surgical template fractures: 3.5% Treatment plan changes: 2% Implant loss by absence of primary stability: 10.2% prosthesis fractures: 2.9% Misfit of the prostheses: 18% need for extensive occlusal adjustments: 4,6% | 1 |
| Moraschini et al (2015) | SR + M‐A | 2 accuracy studies of 13 clinical studies in total |
1.13 mm; [NR]; (NR) |
1.46 mm; [NR]; (NR) |
4.57 mm; [NR]; (NR) |
Low implant stability (10) Fracture of guide (7) Misfit of the guide (6) Implant fenestration (4)
Implant failure (3%) Infections (8%) Low primary stability (10%) Persistent pain (2%) Peri‐implantitis (14%)
Fracture of the prosthesis in (8/14) Adjustments due to Misfit in (8/14) Loosening of components in (6/1$) | 1 |
| Raico Gallardo et al (2016) | SR + M‐A |
4 accuracy studies used in the Meta‐Analysis, divided into groups comparing mucosa‐supported vs tooth‐supported vs bone‐supported guides |
higher accuracy for the mucosa‐supported (
0.48 mm; [0.17‐0.78] (NR)
Tooth‐supported guides statistically higher accuracy (
−0.37 mm; [−0.66 to −0.09] (NR)
no significant difference
0.09 mm; [−0.10 to 0.29] (NR) |
higher accuracy for mucosa‐supported (
0.48 mm; [0.03‐0.93] (NR)
Higher accuracy for the tooth‐supported guides (
−0.50 mm; [−0.80 to −0.20] (NR)
no significant difference
0.01 mm; [−0.33 to 0.35] (NR) |
Greater reduction in the angle deviation in mucosa‐supported guides (
1.08 mm; [0.18‐1.99] (NR)
Deviation was statistically lower when tooth‐supported (
1.41 mm; [1.82 to −0.99] (NR)
no significant difference
0.42 mm; [1.30‐0.45] (NR) | (NR) | 1 |
| Bover‐Ramos et al (2018) | SR + M‐A |
34 accuracy studies 22/34 in vivo studies | 1.10 mm; [0.91‐1.28]; (NR) | 1.40 mm; [1.16‐1.64]; (NR) | 3.98 mm; [3.31‐6.62]; (NR) | (NR) | 1 |
| D'haese et al (2012) | SR |
31 studies 4/31 in vivo studies reporting on accuracy | 1.04 mm; [NR]; (NR) | 1.64 mm; [NR]; (NR) | 3.54 mm; [NR]; (NR) |
Low implant stability Fracture of guide Misfit of the guide
Moderate postoperative pain Marginal fistula Peri‐implant pathology
Occlusal material fracture of the prosthesis Loosening of retaining screws Slight discrepancies between the abutments and implants Midline deviation of prosthetic rehabiliations Fractures of the complete acrylic denture | 1 |
Abbreviations: CS, conventional surgery; F‐FL, freehanded flapless; FL, flapless; G‐FL, guided flapless; GS, guided surgery; LR, Literature Review; M‐A, meta‐analysis; NR, not reported;R, review; S, systematic review.
Evaluation of formal ethical approval in all studies included in the following 9 reviews; (1) Schneider et al 2009, (2) Lin et al 2014, (3) Moraschini et al 2015, (4) Voulgarakis et al 2014, (5) Tahmaseb et al 2014, (6) Vohra et al 2015, (7) Raico Gallardo et al 2016, (8) Bover‐Ramos et al 2018, (9) D'haese et al 2012
| Reference | Cited in review paper | Type of study | Ethical committee approval |
|---|---|---|---|
| Van de Velde et al 2010 | 2, 6 | RCT | EC‐A |
| Tsoukaki M et al 2013 | 6 | RCT | EC‐A |
| Bashutski et al 2013 | 2, 6 | RCT | EC‐A |
| Vercruyssen et al 2014 | 8 | RCT | EC‐A |
| Arisan et al 2010 | 5, 7, 8 | PCCT | EC‐A |
| Di Giacomo et al 2005 | 1, 8, 9 | PCS | EC‐A |
| Van Steenberghe et al 2005 | 1 | PCS | EC‐A |
| Ersoy et al 2008 | 5 | PCS | EC‐A |
| Johansson et al 2009 | 3 | PCS | EC‐A |
| Ozan et al 2009 | 1, 7, 8, 9 | PCS | EC‐A |
| Van Assche et al 2010 | 8 | PCS | EC‐A |
| Ozan et al 2011 | 5 | PCS | EC‐A |
| Vasak et al 2011 | 8 | PCS | EC‐A |
| Platzer et al 2011 | 5 | PCS | EC‐A |
| Arisan et al 2012 | 5 | PCS | EC‐A |
| Pettersson et al 2012 | 5, 8 | PCS | EC‐A |
| D'haese et al 2012 | 8 | PCS | EC‐A |
| Katsoulis J et al 2012 | 6 | PCS | EC‐A |
| D'haese et al 2012 | 3 | PCS | EC‐A |
| Di Giacomo et al 2012 | 3, 8 | PCS | EC‐A |
| Vasak et al 2012 | 4 | PCS | EC‐A |
| Landazurri et al 2013 | 3 | PCS | EC‐A |
| Arisan et al 2013 | 8 | PCS | EC‐A |
| Browaeys et al 2014 | 3 | PCS | EC‐A |
| Verhamme et al 2014 | 8 | PCS | EC‐A |
| Van de Wiele et al 2014 | 8 | PCS | EC‐A |
| De Bruyn et al 2011 | 2, 6 | RCCT | EC‐A |
| Cassetta et al 2012a | 8 | RCCT | EC‐A |
| Ersoy et al 2008a | 7 | RCS | EC‐A |
| Ersoy et al 2008b | 8 | RCS | EC‐A |
| Komiyama et al 2008 | 1 | RCS | EC‐A |
| Komiyama et al 2012 | 3 | RCS | EC‐A |
| Cassetta et al 2012b | 7 | RCS | EC‐A |
| Cassetta et al 2012b | 8 | RCS | EC‐A |
| Ozan et al 2007 | 2 | RCT | EC‐NA |
| Covani et al 2008 | 2 | RCT | EC‐NA |
| Froum SJ et al 2011 | 6 | RCT | EC‐NA |
| Cannizzaro et al 2011 | 2 | RCT | EC‐NA |
| Froum et al 2011 | 2 | RCT | EC‐NA |
| Al‐Juboori MJ et al 2012 | 6 | RCT | EC‐NA |
| Sunitha and Sapthagiri 2013 | 2, 6 | RCT | EC‐NA |
| Chen et al 2010 | 8 | PCCT | EC‐NA |
| Beretta et al 2014 | 8 | PCCT | EC‐NA |
| Fortin et al 2004 | 1 | PCS | EC‐NA |
| Wittwer el al. 2007 | 4 | PCS | EC‐NA |
| Malo et al 2007 | 3 | PCS | EC‐NA |
| Rao and Benzi 2007 | 4 | PCS | EC‐NA |
| Malo et al 2008 | 2, 6 | PCS | EC‐NA |
| Job et al 2008 | 6 | PCS | EC‐NA |
| Gillot et al 2010 | 3 | PCS | EC‐NA |
| Nikzad and Azari 2010 | 4 | PCS | EC‐NA |
| Behneke et al 2012 | 5, 8 | PCS | EC‐NA |
| Marra et al 2013 | 3 | PCS | EC‐NA |
| Berdougo et al 2010 | 4 | RCCT | EC‐NA |
| Rousseau 2010 | 2 | RCCT | EC‐NA |
| Campelo and Camara 2002 | 4 | RCS | EC‐NA |
| Fortin et al 2003 | 1 | RCS | EC‐NA |
| Vrielinck et al 2003 | 1 | RCS | EC‐NA |
| Nickenig and Eitner 2007 | 1 | RCS | EC‐NA |
| Sanna et al 2007 | 1 | RCS | EC‐NA |
| Sennerby et al 2008 | 2 | RCS | EC‐NA |
| Yong and Moy 2008 | 1 | RCS | EC‐NA |
| Valente et al 2009 | 8, 9 | RCS | EC‐NA |
| Puig 2010 | 3 | RCS | EC‐NA |
| Nickenig et al 2010 | 5, 8 | RCS | EC‐NA |
| Meloni et al 2010 | 3 | RCS | EC‐NA |
| Rousseau 2010 | 4 | RCS | EC‐NA |
| Jeong et al 2011 | 4 | RCS | EC‐NA |
| Cassetta et al 2013a | 5, 8 | RCS | EC‐NA |
| Cassetta et al 2013b | 8 | RCS | EC‐NA |
| Mischkowski et al 2006 | 1 | ‐ | ‐ |
Abbreviations: EC‐A, ethical approval available; EC‐NA, ethical approval not available; PCCT, prospective case control trial; PCS, prospective case series; RCCT, retrospective case control trial; RCS, retrospective case series; RCT, randomized clinical trial.
Overview of the total number of clinical studies, corresponding ethical committee approval, and scientific level of evidence as described by the Oxford Centre for Evidence‐Based Medicine (2011)
| Study design | Number of studies with ethical committee approval | Number of studies with no mention of ethical committee approval | Level of evidence |
|---|---|---|---|
| RCT | 4 | 7 | 2 |
| PCCT | 1 | 2 | 3 |
| PCS | 21 | 11 | 4 |
| RCCT | 2 | 2 | 3 |
| RCS | 6 | 15 | 4 |
| Total number | 34 | 37 | 71 |
Abbreviations: EC‐A, ethical approval available; EC‐NA, ethical approval not available; PCCT, prospective case control trial; PCS, prospective case series; RCCT, retrospective case control trial; RCS, retrospective case series; RCT, randomized clinical trial.